Deltex Medical Share Discussion Threads

[bigt20] 19/7/2016 01:41

I'm amazed that people are so relaxed about the £2m+ cash outflow during 1H16.

[bigt20] 15/7/2016 20:16

Placing of 10,465,116 ordinary shares - RNS dated 1/7/16

Interesting that there was a transaction for 4,234,355 disclosed on the 4/7/16 for 4.3p and some 100,000 transactions.

[arf dysg] 15/7/2016 16:46

RNS Number : 3706E / Deltex Medical Group PLC / 15 July 2016

Andrew Muir / transaction 14 July 2016 / notified 14 July 2016

Thresholds crossed 3%, 4%

GB0059337583

OLD:_ 4,634,355
NEW: 13,649,471 (4.79%)

[cisk] 15/7/2016 16:45

Yes that's the chap. Although the RNS said that his holding increased by 9,015,116 shares and the subscription on the 1st July was for 10,465,116 shares.

maybe he sold the difference in the market (as he bought them for 4.3p)? Making a quick £10k profit.

Anyone know anything about him?

I wonder if this is the same person:
hxxp://rainbowseedfund.com/team-member/dr-andrew-muir-investment-director-and-fund-principal/

Anyway - I view this as a positive - a PI stumping up £450k. Maybe he is The Count!

[djgrantb] 15/7/2016 16:27

Lol, you couldn't make this up. Is it right to assume that Andrew Muir was the shareholder that purchased £450k worth of new stock to assist the cash flow situation??

[djgrantb] 15/7/2016 14:09

Nice tick up, large trade coming through or RNS?

[arf dysg] 13/7/2016 16:13

Help! We're doomed!

[zho] 13/7/2016 12:09

Yes. Fact.

;-)

[arf dysg] 13/7/2016 12:06

Is this the beginning of a long slow climb of the share price?

[djgrantb] 12/7/2016 14:16

This share price defies logic, almost 190k bought and 48k sold, share price down, the MMs are having a laugh.... Strong buys the other day, the share price rises before any trades go through and doesn't move a jot all day....

[the count] 11/7/2016 12:06

--->ALL

Excellent news on a head to head trial with this 'most commonly used other technology' here in the UK.

We know it's a PPWA monitor and that it was developed at St. Thomas's Hospital. I wonder which company's product they may be trying to refer to without naming the other company directly? :-) :-)

Interesting too, that this other company has no news release to tell us of this latest trial news. I do wonder how they might try to spin this outcome this time round.

But it also shows up the idiotic, and dangerous thinking, of those medics who opted to use this other technology without the evidence base to back it up.

Absolutely disgusting in my book... along with the decision to use this 'other technology' in that large UK wide trial which damaged the market for fluid management even further by not showing any benefit. It makes me wonder why those (criminal) trial organisers opted to use a technology that had previously had no supporting evidence over a technology (ours) that did. Heads should roll for that, but of course, they are untouchable whatever they get wrong in our wonderful NHS.

Coupled with today's news and the recent large Spanish trial favouring us, hopefully it will help to arrest the rot in the NHS, no matter how incompetent they have shown themselves to be in this particular matter.

Regards,

THE COUNT!

[djgrantb] 11/7/2016 11:23

Nice buying this morning, still think someone is stake building trying to keep a cap on the share price rising. With positive news 6p soon...

[zho] 11/7/2016 09:27

Interview at

[february 30th] 11/7/2016 09:11

EP sounds upbeat on Proactive Investor.

(Google Deltex and "Brexit won’t affect us").

[zho] 11/7/2016 08:05

Results from head to head trial presented

Significantly better outcomes from ODM

Deltex Medical Group plc (LSE-AIM: DEMG), the global leader in oesophageal Doppler monitoring ("ODM"), today announces initial results from the first randomised controlled trial to compare post-operative outcomes when using ODM to the most commonly used alternative technology.

[bigt20] 10/7/2016 13:55

Wigwammer (post 8202)

The 1500 probes per month sold in the US covers the costs of the US sales team.



My understanding is that part of this spend has been to enable the cost reductions and margin improvement necessary to get them to break even.

---> Care to explain more please.

[gnnmartin] 08/7/2016 17:53

The continuing fall off in the UK is appalling, but at least the rte of growth in the USA looks like starting to outweigh the rate of decline in the UK.

[wigwammer] 08/7/2016 10:53

DJT -Your point is correct - cash burn has been high.My understanding is that part of this spend has been to enable the cost reductions and margin improvement necessary to get them to break even.Bottom line - if they get to 1500 probes in the US, they are in a good place ie cash neutrality (all other things being equal).Cheers, we

[arf dysg] 08/7/2016 10:43

Probe revenues from the USA are now bigger than probe revenues from the UK. On the one hand, that sounds impressive. On the other hand, the actual revenues are still quite small: GBP0.9m v. GBP0.8m

[dj trading] 08/7/2016 09:46

Foz - But what about this?

£2.67m less £1m Amati loan - Net £1.6m after expenses

[yump] 08/7/2016 09:43

I don't think I'm imagining it, but I'm sure I heard fluid management/after care mentioned briefly in a TV piece about the investigations of deaths at Southern Health Trust recently. It does beggar belief that improvements take such an effort to implement.

Noone can really say that its money related or pressure related, because the same structural problems of adopting new tech. have been there in the NHS for years as far as I can remember.

[fozdad] 08/7/2016 09:27

Yes, your figures are incorrect.

There was £575k at 31/12/15, they raised £516k and had £500k at 30/6/16.

That's cashburn of £100k per month and that is considerably less than last year, so cash breakeven shouldn't be too far away if US sales continue to rise

[dj trading] 08/7/2016 08:27

Where has all the cash gone? or is £0.5m a typo?

Buy my very quick calculation - cashburn for 1H is around £2.3m or nearly 400k/month!?

Surely this is incorrect?